Silver Book Fact

The use of sodium oxybate (SXB) in fibromylagia patients reduced pain by 30% or more in 54-58% of patients (versus 35.2% for placebo). SXB also reduced fatigue and sleep disturbance.

Russell I, Holman A, Swick T, et al. Sodium Oxybate Reduces Pain, Fatigue, and Sleep Disturbance and Improves Functionality in Fibromyalgia: Results from a 14-week randomized, double-blind, placebo-controlled study. Pain. 2011; 152(5): 1007-17. http://www.ncbi.nlm.nih.gov/pubmed/21397402

Reference

Title
Sodium Oxybate Reduces Pain, Fatigue, and Sleep Disturbance and Improves Functionality in Fibromyalgia: Results from a 14-week randomized, double-blind, placebo-controlled study
Publication
Pain
Publication Date
2011
Authors
Russell I, Holman A, Swick T, et al
Volume & Issue
Volume 152, Issue 5
Pages
1007-17
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • An oral cannabinoid was found effective in relieving diabetic peripheral neuropathic pain symptoms and improving disturbed sleep, quality of life, and overall patient status.  
  • A meta-analysis of antidepressants found that 1 in 3 patients with persistent neuropathic pain will get at least moderate pain relief. Another meta-analysis of duloxetine found it useful for…  
  • A biopsychosocial approach (i.e., one that takes into account physical, emotional, and environmental factors in the assessment and treatment of pain) has been found to improve the pain care of…  
  • Brain imaging is showing that pain changes the structure and function of brain regions that perceive pain, making it persistent. These brain networks and receptor targets are being identified…  
  • A meta-analysis of duloxetine, an anti-depressant, found a 50% reduction in pain at 12 weeks for diabetic peripheral neuropathy, and a 50% reduction in pain at 12 weeks for fibromyalgia.